The Drug Development and Approval Process | FDAReview.org
Clinical Trial Phases | CERN Foundation
Investigational New Drugs: FDA Has Taken Steps to Improve the Expanded Access Program but Should Further Clarify How Adverse Events Data Are Used | U.S. GAO